Effects of Curative-Intent Treatments on Hepatocellular Carcinoma Survival in Alcohol-Related Cirrhosis: A Nationwide Study

References

• Sung H, Ferlay J, Siegel RL., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Akinyemiju T, Abera S, Ahmed M; Collaboration GBoDLC. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3(12):1683–1691. doi:10.1001/jamaoncol.2017.3055
   PubMed Web of Science ®Google Scholar
• Deleuran T, Vilstrup H, Jepsen P. Decreasing Mortality Among Danish Alcoholic Cirrhosis Patients: a Nationwide Cohort Study. Am J Gastroenterol. 2016;111(6):817–822. doi:10.1038/ajg.2016.107
   PubMed Web of Science ®Google Scholar
• Makkar N, Ostrom QT, Kruchko C, Barnholtz-Sloan JS. A comparison of relative survival and cause-specific survival methods to measure net survival in cancer populations. Cancer Med. 2018;7(9):4773–4780. doi:10.1002/cam4.1706
   PubMed Web of Science ®Google Scholar
• Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007;8(3):576–594. doi:10.1093/biostatistics/kxl030
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Zhong J, Berhane S, et al. The chances of hepatic resection curing hepatocellular carcinoma. J Hepatol. 2020;72(4):711–717. doi:10.1016/j.jhep.2019.11.016
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/clep.S91125
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7 Suppl):42–45. doi:10.1177/1403494810393562
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011;39(7 Suppl):26–29. doi:10.1177/1403494811399958
   PubMed Web of Science ®Google Scholar
• EASL Clinical Practice. Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010;39(2):598–610. doi:10.1093/ije/dyp392
   PubMed Web of Science ®Google Scholar
• Kragh Andersen P, Pohar Perme M. Pseudo-Observations in Survival Analysis Research report, 08/12 1. Department of Biostatistics, University of Copenhagen;2008.
   Google Scholar
• Hakulinen T, Seppä K, Lambert PC. Choosing the relative survival method for cancer survival estimation. Eur J Cancer. 2011;47(14):2202–2210. doi:10.1016/j.ejca.2011.03.011
   PubMed Web of Science ®Google Scholar
• McLachlan GJ, McGiffin DC. On the role of finite mixture models in survival analysis. Stat Methods Med Res. 1994;3(3):211–226. doi:10.1177/096228029400300302
   PubMedGoogle Scholar
• Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017;34(2):153–159. doi:10.1053/j.semdp.2016.12.011
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM, Lee JY, et al. Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: long-term Results and Prognostic Factors in 162 Patients with Cirrhosis. Radiology. 2014;270(3):900–909. doi:10.1148/radiol.13130940
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Del Prete V, Antonino M, et al. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation. Digestive Liver Dis. 2014;46(11):1014–1019. doi:10.1016/j.dld.2014.07.012
   Web of Science ®Google Scholar
• Schaffar R, Rachet B, Belot A, Woods L. Cause-specific or relative survival setting to estimate population-based net survival from cancer? An empirical evaluation using women diagnosed with breast cancer in Geneva between 1981 and 1991 and followed for 20 years after diagnosis. Cancer Epidemiol. 2015;39(3):465–472. doi:10.1016/j.canep.2015.04.001
   PubMed Web of Science ®Google Scholar
• Jepsen P, Andersen MW, Villadsen GE, Ott P, Vilstrup H. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: a nationwide register-based cohort study. Liver Int. 2017;37(6):871–878. doi:10.1111/liv.13340
   PubMed Web of Science ®Google Scholar
• Bright CJ, Brentnall AR, Wooldrage K, Myles J, Sasieni P, Duffy SW. Errors in determination of net survival: cause-specific and relative survival settings. Br J Cancer. 2020;122(7):1094–1101. doi:10.1038/s41416-020-0739-4
   PubMed Web of Science ®Google Scholar
• Cho H, Klabunde CN, Yabroff KR, et al. Comorbidity-Adjusted Life Expectancy: a New Tool to Inform Recommendations for Optimal Screening Strategies. Ann Intern Med. 2013;159(10):667–676. doi:10.7326/0003-4819-159-10-201311190-00005
   PubMed Web of Science ®Google Scholar
• Mariotto AB, Wang Z, Klabunde CN, Cho H, Das B, Feuer EJ. Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients. J Clin Epidemiol. 2013;66(12):1376–1385. doi:10.1016/j.jclinepi.2013.07.002
   PubMed Web of Science ®Google Scholar
• Tan KS, Eguchi T, Adusumilli PS. Reporting net survival in populations: a sensitivity analysis in lung cancer demonstrates the differential implications of reporting relative survival and cause-specific survival. Clin Epidemiol. 2019;11:781–792. doi:10.2147/CLEP.S210894
   PubMed Web of Science ®Google Scholar
• Pinna AD, Yang T, Mazzaferro V, et al. Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma. Ann Surg. 2018;268(5):868–875. doi:10.1097/sla.0000000000002889
   PubMed Web of Science ®Google Scholar
• Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry--history, content, quality and use. Dan Med Bull. 1997;44(5):535–539.
   PubMedGoogle Scholar
• Vestberg K, Thulstrup AM, Sørensen HT, Ottesen P, Sabroe S, Vilstrup H. Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. J Med Syst. 1997;21(1):11–20.
   PubMedGoogle Scholar
• Kjærgaard J, Clemmensen IH, Thomsen BL, Storm HH. Validity of diagnoses of and operations for nonmalignant gynecological conditions in the Danish National Hospital Registry. J Clin Epidemiol. 2002;55(2):137–142. doi:10.1016/S0895-4356(01)
   PubMed Web of Science ®Google Scholar
• Harboe KM, Anthonsen K, Bardram L. Validation of data and indicators in the Danish Cholecystectomy Database. Int J Qual Health Care. 2009;21(3):160–168. doi:10.1093/intqhc/mzp009
   PubMed Web of Science ®Google Scholar
• Chen HL, Chen YH, Du L, Song YP, Zhu B. Elevated serum alpha-fetoprotein levels are associated with poor prognosis of hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis. Arab J Gastroenterol. 2021;22(1):12–22. doi:10.1016/j.ajg.2020.09.004
   PubMed Web of Science ®Google Scholar
• Lee S, Rhim H, Kim YS, Kang TW, Song KD. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma. Liver Int. 2016;36(4):580–587. doi:10.1111/liv.12991
   PubMed Web of Science ®Google Scholar
• Utsunomiya T, Shimada M, Kudo M, et al. A Comparison of the Surgical Outcomes Among Patients With HBV-positive, HCV-positive, and Non-B Non-C Hepatocellular Carcinoma: a Nationwide Study of 11,950 Patients. Ann Surg. 2015;261(3):513–520. doi:10.1097/SLA.0000000000000821
   PubMed Web of Science ®Google Scholar
• Marasco G, Colecchia A, Colli A, et al. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection. J Hepatol. 2019;70(3):440–448. doi:10.1016/j.jhep.2018.10.022
   PubMed Web of Science ®Google Scholar